Auto-injectors Market, By Product Type (Prefilled Auto-Injectors, Fillable Auto-Injectors), By Disease Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Phar

Auto-injectors Market, By Product Type (Prefilled Auto-Injectors, Fillable Auto-Injectors), By Disease Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Auto- injector is a medical device which can deliver dose of medications. Auto injectors are easy to use and self-administration by patients is possible. Auto-injectors come under injectable drug delivery which is considered as the most effective route of administration for the effective delivery of drugs to the targeted site, which enhances the patient’s compliance to the drug. The Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action. Epinephrine auto-injector is a type of auto-injector widely used for people at risk of anaphylaxis. Auto-injectors are often used in the military to protect personnel from chemical warfare agents.
Restraints of the Global Auto-Injectors Market
High cost of auto-injectors, and stringent regulatory scenario are the major factors hindering growth of the global auto-injectors market. The cost of EpiPen (2-pack) increased from US$ 100 in 2007 to US$ 608. Moreover, the cost of a generic EpiPen launched in December 2016 was 300% more than that in 2007.
Key features of the study:
This report provides in-depth analysis of the global auto-injectors market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global auto-injectors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton, Dickinson and Company, Sanofi, Pfizer, Inc., Mylan N.V., Novartis AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global auto-injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Auto-Injectors Market, By Product Type:
Prefilled Auto-Injectors
Fillable Auto-Injectors
Global Auto-Injectors Market, By Disease Indication:
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
Global Auto-Injectors Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Auto-Injectors Market, By Geography:
North America
By Product Type
Prefilled Auto-Injectors
Fillable Auto-Injectors
Disease Indication
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
By End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Europe
By Product Type
Prefilled Auto-Injectors
Fillable Auto-Injectors
Disease Indication
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
By End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Prefilled Auto-Injectors
Fillable Auto-Injectors
Disease Indication
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
By End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type
Prefilled Auto-Injectors
Fillable Auto-Injectors
Disease Indication
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
By End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Product Type
Prefilled Auto-Injectors
Fillable Auto-Injectors
Disease Indication
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
By End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type
Prefilled Auto-Injectors
Fillable Auto-Injectors
Disease Indication
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
By End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Becton, Dickinson and Company *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Sanofi S.A.
Pfizer, Inc.
Mylan N.V.
Novartis International AG
Bayer AG
Janssen Global Services Llc
Antares Pharma, Inc.
Amgen Inc.
Eli Lilly and Co.
“*” marked represents similar segmentation in other categories in the respective section.